Inhibition of Breast Cancer Growth and Metastasis by Gene Therapy
Author Information
Author(s): Peng Xing-Chen, Yang Li, Yang Li-Ping, Mao Yong-Qiu, Yang Han-Shuo, Liu Ji-Yan, Zhang Dong-Mei, Chen li-Juan, Wei Yu-Quan
Primary Institution: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University
Hypothesis
Can the Msurvivin T34A plasmid effectively suppress murine breast cancer growth and metastasis?
Conclusion
The Msurvivin T34A plasmid complexed with cationic liposome may effectively inhibit the growth and metastasis of a highly metastatic mouse breast cancer model with minimal side effects.
Supporting Evidence
- Treatment with Msurvivin T34A plasmid resulted in a 73% reduction in primary tumor growth compared to control.
- Mice treated with Msurvivin T34A had significantly fewer lung metastases.
- 4 out of 10 mice treated with Msurvivin T34A had no visible lung metastases.
- Apoptosis rates were significantly higher in tumors treated with Msurvivin T34A.
- Microvessel density was significantly lower in tumors treated with Msurvivin T34A.
Takeaway
Scientists found a way to help mice with breast cancer by using a special gene that makes their tumors shrink and stop spreading.
Methodology
The study involved treating mice with a plasmid encoding a mutant survivin gene and measuring tumor growth and metastasis.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Female BALB/c mice, aged 6 to 8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website